Eiji Takeuchi

Kochi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study.

Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study.

Journal: Thoracic cancer

Published: March 06, 2026

Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature review.

Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature review.

Journal: Medicine

Published: July 15, 2025

Incidence of RSV- and Influenza-Associated Hospitalizations With Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022-2024: APSG-J2 Study.

Incidence of RSV- and Influenza-Associated Hospitalizations With Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022-2024: APSG-J2 Study.

Journal: Influenza and other respiratory viruses

Published: July 04, 2025

Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.

Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.

Journal: Thoracic cancer

Published: October 09, 2024

Pulmonary cavitary disease due to Mycobacterium intracellulare cured in a healthy young adult leaving only calcifications.

Pulmonary cavitary disease due to Mycobacterium intracellulare cured in a healthy young adult leaving only calcifications.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: September 30, 2024

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Journal: International journal of clinical oncology

Published: June 06, 2024

Suspected Aspergillus nodule histologically consistent with pulmonary nodular lymphoid hyperplasia:a case report.

Suspected Aspergillus nodule histologically consistent with pulmonary nodular lymphoid hyperplasia:a case report.

Journal: The journal of medical investigation : JMI

Published: November 08, 2023

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations.

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations.

Journal: Thoracic cancer

Published: September 19, 2023

An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Thoracic cancer

Published: September 13, 2023

Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Thoracic cancer

Published: July 21, 2023

A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.

A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.

Journal: Thoracic cancer

Published: June 06, 2023

Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib.

Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib.

Journal: Thoracic cancer

Published: November 07, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026